Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32182097.
- Also identified by DOI 10.2214/AJR.19.21819.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> The purpose of this article is to review the epidemiologic aspects of cervical cancer, the 2018 revised International Federation of Gynecology and Obstetrics (FIGO) staging system, and the role of imaging in the staging of cervical cancer. <b>CONCLUSION.</b> Cervical cancer has many prognostic factors, some of which, such as lymph node metastasis, were not included in the original FIGO staging system. FIGO has issued a revised staging system that encompasses additional prognostic factors to facilitate adequate management.
Medical subject headings
- Uterine Cervical Neoplasms